Efficacy of glutamine in the prevention of oral mucositis and acute radiation-induced esophagitis: A retrospective study

Nutrition and Cancer

Volumn 65, Issue 3, 2013, Pages 424-429

  Vidal Casariego, Alfonso ^a   Calleja Fernández, Alicia ^a   Ballesteros Pomar, María D ^a   Cano Rodríguez, Isidoro ^a  

^a Gerencia Regional de Salud de Castilla y León   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMINE; OPIATE;

ADULT; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COHORT ANALYSIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; EARLY INTERVENTION; ESOPHAGITIS; FEMALE; HEAD AND NECK CANCER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MELANOMA; ORAL MUCOSITIS; QUANTITATIVE ANALYSIS; RADIATION INJURY; RETROSPECTIVE STUDY; RISK REDUCTION; WEIGHT REDUCTION;

AGED; ANTINEOPLASTIC AGENTS; BODY MASS INDEX; COHORT STUDIES; ENTERAL NUTRITION; ESOPHAGITIS; FEMALE; GLUTAMINE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; RADIOTHERAPY; RETROSPECTIVE STUDIES; STOMATITIS; WEIGHT LOSS;

EID: 84876108884     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.765017     Document Type: Article

References (32)

1. Trotti, A, Bellm, L A, Epstein, J B, Frame, D, Fuchs, H J. 2003. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol, 66: 253-262.
2. Belderbos, J, Heemsbergen, W, Hoogeman, M, Pengel, K, Rossi, M. 2005. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol, 75: 157-164.
3. Murphy, B A. 2007. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Support Oncol, 5: 13-21.
4. Rosenthal, D I. 2007. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol, 5 (9, Suppl 4): 23-31.
5. García-Peris, P, Lozano, M A, Velasco, C, de La Cuerda, C, Iriondo, T. 2005. Prospective study of resting energy expenditure changes in head and neck cancer patients treated with chemoradiotherapy measured by indirect calorimetry. Nutrition, 21: 1107-1112.
6. García-Peris, P, Parón, L, Velasco, C, de la Cuerda, C, Camblor, M. 2007. Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: Impact on quality of life. Clin Nutr, 26: 710-717.
7. van den Berg, M G, Rasmussen-Conrad, E L, Gwasara, G M, Krabbe, P F, Naber, A H. 2006. A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr, 25: 765-772.
8. Sonis, S T, Elting, L S, Keefe, D M, Peterson, D E, Schubert, M. 2004. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer, 100: 1995-2025.
9. Khan, S A, and, Wingard, J R. 2001. Infection and mucosal injury in cancer treatment. J Nat Cancer Inst Mono, 29: 31-36.
10. Kouvaris, J R, Kouloulias, V E, and, Vlahos, L J. 2007. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist, 12: 738-747.
11. Kim, J H, Chu, F C, Lakshmi, V, and, Houde, R. 1986. Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol, 9: 132-134.
12. Epstein, J B, Silverman, S Jr, Paggiarino, D A, Crockett, S, Schubert, M M. 2001. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer, 92: 875-885.
13. Kazemian, A, Kamian, S, Aghili, M, Hashemi, F A, and, Haddad, P. 2009. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care (Engl), 18: 174-178.
14. Rashad, U M, Al-Gezawy, S M, El-Gezawy, E, and, Azzaz, A N. 2009. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. J Laryngol Otol, 123: 223-228.
15. Worthington, H V, Clarkson, J E, and, Eden, O B. 2007. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev, 17 (4): CD000978
16. Huang, E Y, Leung, S W, Wang, C J, Chen, H C, Sun, L M. 2000. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys, 46: 535-539.
17. Cerchietti, L C, Navigante, A H, Lutteral, M A, Castro, M A, Kirchuk, R. 2006. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys, 65: 1330-1337.
18. Algara, M, Rodríguez, N, Viñals, P, Lacruz, M, Foro, P. 2007. Prevention of radiochemotherapy-induced esophagitis with glutamine: results of a pilot study. Int J Radiat Oncol Biol Phys, 69: 342-349.
19. Topkan, E, Yavuz, M N, Onal, C, and, Yavuz, A A. 2009. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters. Lung Cancer, 63: 393-399.
20. Young, V R, and, Ajami, A M. 2001. Glutamine: the emperor or his clothes?. J Nutr, 131: 2449S-2459S.
21. Roth, E. 2007. Immune and cell modulation by amino acids. Clin Nutr, 26: 535-544.
22. Newsholme, P. 2001. Why is L-glutamine metabolism important to cells of the immune system in health, surgery or infection?. J Nutr, 131: 2515S-2522S.
23. Curi, R, Lagranha, C J, Doi, S Q, Sellitti, D F, Procopio, J. 2005. Molecular mechanism of glutamine action. J Cell Phys, 204: 392-401.
24. Worthington, H V, Clarkson, J E, Bryan, G, Furness, S, Glenny, A M. 2011. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews, 4. Art. No. CD000978 doi: 10.1002/14651858
25. Le, Q T, Kim, H E, Schneider, C J, Muraközy, G, Skladowski, K. 2011. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol, 29: 2808-2814.
26. Keefe, D M, Schubert, M M, Elting, L S, Sonis, S T, Epstein, J B. 2007. Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer, 109: 820-831.
27. Kim, J H, Chu, F C, Lakshmi, V, and, Houde, R. 1986. Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol, 9: 132-134.
28. Epstein, J B, Silverman, S Jr, Paggiarino, D A, Crockett, S, Schubert, M M. 2001. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer, 92: 875-885.
29. Kazemian, A, Kamian, S, Aghili, M, Hashemi, F A, and, Haddad, P. 2009. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care (Engl), 18: 174-178.
30. Crowther, M, Avenell, A, and, Culligan, D J. 2009. Systematic review and meta-analyses of studies of glutamine supplementation in hematopoietic stem cell transplantation. Bone Marrow Transplantation, 44: 413-425.
31. Yoshida, S, Matsui, M, Shirouzu, Y, Fujita, H, Yamana, H. 1998. Effects of glutamine supplements and chemoradiotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg, 227: 485-491.
32. Isenring, E A, Bauer, J D, and, Capra, S. 2007. Nutrition support using the American Dietetic Association Medical Nutrition Protocol for radiation oncology patients improves dietary intake compared with standard practice. J Am Diet Assoc, 107: 404-412.